OIS Podcast | Ophthalmology's leading Podcast

10 Episodes
Subscribe

By: OIS Podcast

Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.

A Visionary Approach to Uveitis: Tarsier Pharma’s Disruptive Innovation
#411
Last Friday at 2:00 PM

In this OIS Podcast episode, host Dr. Robert Rothman sits down with Daphne Haim-Langford, PhD, Founder & CEO of Tarsier Pharma, and Ashley Kline, Chief Commercial Officer, to discuss their groundbreaking approach to uveitis treatment.

Tarsier’s lead candidate, TRS01, is a first-in-class bio-inspired therapy designed to control inflammation without raising intraocular pressure, a major complication of steroid treatments. With a unique mechanism of action that modulates macrophages and reduces inflammation, this novel drug has the potential to redefine uveitis and glaucoma care.

 

In this episode, you’ll learn:

🔹 How Tarsier’s bio-inspir...


Next-Gen Innovators: Dr. Vikram Shankar on Advancing Patient Safety and Sustainability with Dropmate
#410
01/31/2025

In this episode of Eye on Innovation, host Carey Powers introduces the Next-Gen Innovators series with special guest Dr. Vikram Shankar, an ophthalmologist at Stanford and co-founder of Dropmate. Dr. Shankar discusses how his passion for public health and patient care inspired the creation of Dropmate—a compact, affordable, and eco-friendly disinfection system for clinical eye care equipment. Learn how this technology addresses patient safety, cost savings, and environmental sustainability, all while transforming the standard of care in ophthalmology.

In this episode, you’ll learn:

How Dropmate revolutionizes the disinfection process for eyed...


Insights from a Leader: Dave LeCause on Commercial Strategy and Innovation in Eye Care
#409
01/17/2025

In this episode of The Rob and Jai Show, Dave LeCause, a renowned biopharmaceutical leader and former VP of Allergan Eye Care, reflects on his remarkable career in ophthalmology. Join us as Dave discusses his journey from leading commercial strategies for billion-dollar brands to mentoring the next generation of innovators. Hear his thoughts on innovation cycles, the evolving landscape of dry eye treatments, and why gene and cell therapies hold the key to ophthalmology’s future.

In this episode, you’ll learn:

How Dave LeCause helped shape the commercial success of leading ophthalmic brands.His...


The Power of Collaboration: From Early-Stage Innovation to Commercial Strategy
#408
01/03/2025

In this double-feature episode of the OIS Eye on Innovation Podcast, Carey Powers highlights the invaluable resources and expertise within the OIS community, showcasing the power of cross-collaboration and strategic foresight in biotech.

Part 1:
Dr. Francis Lasowski (C20/20 Innovation Hub) and Dr. Wendy Naimark (Ripple Therapeutics) discuss their long-standing partnership, which has propelled Ripple's success through groundbreaking innovations, including dry AMD research and key advancements in IP management. Learn how the Innovation Hub provides early-stage companies with critical resources to navigate the challenges of development and commercialization.

Part 2:
Tracy...


Redefining Ophthalmic Innovation: Stuart Therapeutics’ Journey Beyond Dry Eye
#407
12/20/2024

In this episode of The Rob and Jai Show from OIS XIV, hosts Dr. Rob Rothman and Dr. Jai Parekh talk with Eric Schlumpf, CEO of Stuart Therapeutics, about the company’s transformative approach to ophthalmic diseases. Learn how Stuart's innovative polypeptide technology repairs damaged collagen, advancing from dry eye to neuroprotection in glaucoma and beyond. Eric highlights key milestones, including promising clinical trial results, strategic partnerships, and the company’s plans to tackle major unmet needs like myopia and inherited retinal diseases.

In this episode, you’ll learn:

How Stuart Therapeutics’ polypeptide platform is revol...


Company Quick Takes
12/06/2024

Carey Powers caught up with five innovative companies at this years OIS XIV in San Diego, to discuss the latest advancements in ophthalmology on the OIS podcast.

Topics included touchless laser therapy for presbyopia, extending the duration of intravitreal treatments, next-generation tear fluid testing, and new imaging methodologies for vitreoretinal conditions. Guests include:

Alex Lopez, Chief Commercial Officer - Ace Vision GroupHouman Hemmati, MD, PhD, Co-Founder & Chief Medical Officer - Optigo BiotherapeuticsLeanne Lavriola, DO, MBA, President & CEO - InnSight TechnologyNir Katchinskiy, PhD, CEO & Co-Founder...


Transforming Corneal Care
#406
11/01/2024

In this episode, listen in as Dr. Robert Rothman speaks with Dr. Daniel Brocks, CMO of BostonSight! They discuss the unique PROSE lenses that are redefining corneal care and how BostonSight’s nonprofit mission is making advanced treatments accessible to more patients. Key takeaways include:

PROSE Lenses: Customized scleral lenses that protect, hydrate, and restore vision for complex eye conditions.Increased Accessibility: BostonSight’s new tech-driven approach to simplify lens fitting for broader use.Mission-Driven Impact: How BostonSight reinvests revenue to offer free care and support for patients in need.

Join us t...


Revolutionizing Eye Surgery
#405
10/18/2024

In this episode of the OIS Retina Podcast, Firas Rahhal sits down with Jean-Pierre Hubschman, CEO of Horizon Surgical, to discuss the revolutionary advancements in robotic eye surgery. Highlights include:

The development of the "IRISS" robotic platform and its focus on cataract surgery.Insights into AI-driven precision, decision-making, and visualization in surgery.Challenges of transitioning from academia to a successful medtech startup.Future potential for robotics in glaucoma, retina, and other ophthalmic procedures.

Listen now to hear how AI and robotics are transforming eye surgery!


The Future of Vision Technology
10/04/2024

In this episode of the OIS Podcast, host Rob Rothman sits down with Jay Cormier, CEO of Eyedaptic, to explore innovative solutions for individuals with vision loss. They discuss Eyedaptic's groundbreaking technology and its impact on enhancing daily life for those with visual impairments.

Key Highlights:

Insight into the inspiration behind Eyedaptic and its mission to improve independence for the visually impaired.Overview of the EYE5 product, an augmented reality solution that enhances mobility and connection to the environment.Discussion on the recent launch of Ivy, an AI visual assistant that transforms user interaction...


Revolutionizing Corneal Health
08/23/2024

In this week’s OIS Podcast episode, Host Dr. Robert Rothman sits down with Almog Aley-Raz, CEO of CorNeat Vision, for a fascinating discussion. They cover:

Almog’s career journey from Israel to the U.S.How a mountain biking trip with an ophthalmologist sparked the idea for CorNeat VisionCorneal blindness as a global issue and the need for better solutions, especially in regions with limited donor tissue and trained surgeonsCorNeat's groundbreaking synthetic cornea, made with their unique material, Avatrix, which offers exciting potential for restoring visionApplications of Avatrix beyond ophthalmology, including maxillofacial and dental procedures

Tune in n...